Israeli Evogene files to raise $60 million on NYSE and Extend Collaboration with Swiss Syngenta

– – Evogene Ltd. (TASE: EVGN) has filed a registration statement with the US Securities and Exchange Commission (SEC) to raise $60 million in a public offering on the New York Stock Exchange. The More...